Skip to main content

Table 3 HRCT scores in men and women with TB at differential time point of anti-TB treatment

From: Sex influences the association between haemostasis and the extent of lung lesions in tuberculosis

 

Female† (n = 15)

Male† (n = 7)

HRCT scores

T0

16.8 (11.23, 22.37)

25.86 (15.19, 36.53)

T1

13.53 (8.45, 18.62)

23.86 (14.8, 32.91)

T3

10.00 (4.89, 15.11)

18.71 (10.24, 27.19)

P valuea

< 0.001

0.001

P valueb

0.044

 

Weighted HRCT scores

T0

38.13 (23.51, 52.75)

48.71 (23.48, 73.95)

T1

32.20 (17.48, 46.92)

52.43 (30.16, 74.69)

T3

23.33 (9.54, 37.13)

41.57 (17.28, 65.86)

P valuea

0.003

0.295

P valueb

0.158

 
  1. HRCT high-resolution computed tomography, T0 time of registration in SPH and before anti-TB treatment, T1 about 1 month after T0, T3 about 3 months after T0
  2. †Data are displayed as means and lower and upper bounds of 95% confidence interval
  3. aANOVA tests with single-factor repeated measures compare the difference of scores at T0, T1 and T3 in female or male TB patients
  4. bANOVA tests with multiple-factor repeated measures compare the changes of scores at T0, T1 and T3 between female and male TB patients
  5. Italicized numbers indicate a P value of < 0.05